Pharmacological effects of phosphatidylserine liposomes: the role of lysophosphatidylserine.
1. Unique among the phospholipids, phosphatidylserine depresses brain energy metabolism when injected intravenously into mice in the form of sonicated liposomes. The possibility that this effect results from a metabolic transformation of phosphatidylserine is examined in this paper. 2. A strong enhancement of the phosphatidylserine effect is induced by the incubation of liposomes with rat serum. Similar phosphatidylserine activation is observed after the incubation of the phospholipid with purified phospholipase A2 from pancreas. In both cases phosphatidylserine is split into the deacylated derivative, lysophosphatidylserine. 3. Lysophosphatidylserine reproduces with greater efficacy the effect of phosphatidylserine on brain energy metabolism. Other lysophospholipids are not effective. 4. It is concluded that the pharmacological effects of phosphatidylserine liposomes is due to the generation of lysophosphatidylserine.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D002417:Cattle; D004734:Energy Metabolism / Q000187:drug effects; D005947:Glucose / Q000378:metabolism; D006168:Guinea Pigs; D006736:Horses; D008081:Liposomes; D008297:Male; D010718:Phosphatidylserines / Q000097:blood / Q000494:pharmacology*; D051381:Rats; D012756:Sheep; D013045:Species Specificity; D013552:Swine
D008081:Liposomes; D010718:Phosphatidylserines; D005947:Glucose